Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J SMALL

Showing results (1091-1100 of 1,203) with videos related to

Pageof 121
Sort By:
Clinical Genitourinary Cancer|June 29, 2017
High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate CancerTerence W Friedlander, Julie N Graff, Kreshnik Zejnullahu, et al.
NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Cancers|June 10, 2023
Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and ControlsKelly Nudelman, Kwangsik Nho, Michael Zhang, et al.
JNCI Cancer Spectrum|March 31, 2024
Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer studyArthur Patrick McDeed, Kathleen Van Dyk, Xingtao Zhou, et al.
British Journal of Cancer|November 11, 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTANJohn Shen, Simon Chowdhury, Neeraj Agarwal, et al.
Prostate Cancer and Prostatic Diseases|March 31, 2025
Racial variation in the advanced prostate cancer genomeEmily M Feng, Jenny Vo-Phamhi, Aishwarya N Subramanian, et al.
Future Oncology (London, England)|March 31, 2025
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
JAMA Network Open|August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN TrialsSoumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
Cancer|July 23, 2016
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)Jeanne S Mandelblatt, Jonathan D Clapp, Gheorghe Luta, et al.
JNCI Cancer Spectrum|May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With DocetaxelSusan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Pageof 121

Showing results (1091-1100 of 1,203) with videos related to

Sort By:
Pageof 121
Clinical Genitourinary Cancer|June 29, 2017
High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate CancerTerence W Friedlander, Julie N Graff, Kreshnik Zejnullahu, et al.
NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Cancers|June 10, 2023
Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and ControlsKelly Nudelman, Kwangsik Nho, Michael Zhang, et al.
JNCI Cancer Spectrum|March 31, 2024
Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer studyArthur Patrick McDeed, Kathleen Van Dyk, Xingtao Zhou, et al.
British Journal of Cancer|November 11, 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTANJohn Shen, Simon Chowdhury, Neeraj Agarwal, et al.
Prostate Cancer and Prostatic Diseases|March 31, 2025
Racial variation in the advanced prostate cancer genomeEmily M Feng, Jenny Vo-Phamhi, Aishwarya N Subramanian, et al.
Future Oncology (London, England)|March 31, 2025
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
JAMA Network Open|August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN TrialsSoumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
Cancer|July 23, 2016
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)Jeanne S Mandelblatt, Jonathan D Clapp, Gheorghe Luta, et al.
JNCI Cancer Spectrum|May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With DocetaxelSusan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Pageof 121